Business UpdateJun 10, 2026, 09:06 AM
Autonomix Medical Gains Scientific Recognition with 13 Abstract Acceptances
AI Summary
Autonomix Medical, Inc. released its latest CEO Corner segment, featuring CEO Brad Hauser, who highlighted the company's growing scientific and clinical recognition. The company has secured 13 abstract acceptances, including 9 podium and 4 poster presentations at major medical conferences, and received a top Cardiovascular Innovation Award at CRT. The segment also outlined how Autonomix's nerve-sensing and targeted therapy approach could transform treatments for complex conditions like pancreatic cancer pain, supporting future clinical trials and partnerships.
Key Highlights
- Autonomix secured 13 abstract acceptances since last fall.
- These include 9 podium presentations and 4 poster presentations.
- Presentations were at major forums like TCT, CRT, SIR, and ASCO.
- Received a top Cardiovascular Innovation Award at CRT.
- Technology aims to transform treatment for conditions like pancreatic cancer pain.
- Supports physician adoption, clinical trials, and strategic partnerships.
Price Impact
More from AMIX